Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth ...

Biomarker testing firm Cleveland HeartLab is still growing fast, and it doesn’t plan on slowing down anytime soon. The three-year-old startup has just tacked an additional $14.7 million in fresh ...

Cleveland HeartLab Inc., a local startup firm that develops biological tests to measure cardiovascular risk, has been on a roll the past few weeks. And the company's success does more than validate ...

Cleveland HeartLab has agreed to be acquired by Quest Diagnostics, a Fortune 500 medical testing company based in New Jersey. The deal should help the Cleveland Clinic spinout company accelerate its ...

CLEVELAND, Ohio - Quest Diagnostics today finalized its acquisition of Cleveland Clinic spinoff Cleveland HeartLab. Cleveland HeartLab, a cardiovascular diagnostic testing company, has proprietary ...

New Zealand-based medtech startup HeartLab has raised $2.45 million in seed funding that it says will help the company expand its AI-powered heart scanning and reporting platform to cardiologists in ...

Cleveland HeartLab Inc. has secured an $18.4 million investment that will help the company expand its employee base, its product lineup and its physical footprint in Cleveland, said CEO Jake Orville.

After hitting several roadblocks in getting grants from the National Institutes of Health and the National Science Foundation, Robert Petrocelli and Dr. Jonathan Elion thought it was time to take ...

Medtech startup HeartLab has raised $2 million in its latest seed round, taking its total funding to around $8m to date. Investors in this round included Californian research scientist and ...

Medtech startup HeartLab has today announced $3.5m has been raised through a funding round led by Silicon Valley’s Founders Fund that will supercharge its entry into the US market early next year.